Metindol Retard

Indometacin, the active ingredient in Metindol Retard, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral formulation for systemic use. It is used to relieve pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis and gout.

GNH USA supplies Metindol Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin is an NSAID that reduces inflammation and pain in several musculoskeletal and crystal‑induced disorders. - Rheumatoid arthritis: decreases joint swelling, pain and stiffness. - Osteoarthritis: alleviates chronic joint pain and improves mobility. - Gout: reduces acute inflammatory attacks and associated discomfort. - Ankylosing spondylitis: lessens spinal inflammation and pain. - Acute pain: provides short‑term relief for severe pain episodes.

Indometacin may cause a range of adverse reactions, from mild to severe, depending on individual susceptibility and duration of therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, abdominal pain. - Headache or dizziness. - Skin rash or pruritus. - Elevated liver enzymes. - Mild renal function changes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe renal impairment or failure. - Hepatotoxicity with jaundice. - Anaphylactic or severe hypersensitivity reactions. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiovascular events such as myocardial infarction or stroke.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Assess gastrointestinal risk: avoid in patients with active ulcers or history of GI bleeding. - Monitor renal function: check serum creatinine and electrolytes regularly. - Use lowest effective dose: limit duration to the shortest period needed for symptom control. - Avoid in known hypersensitivity to indometacin or other NSAIDs. - Caution in cardiovascular disease: consider alternative therapy if high risk. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Indometacin can alter the pharmacokinetics or pharmacodynamics of several medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: reduced renal clearance leading to toxicity. - Methotrexate: enhanced toxicity, especially at high doses. - Other NSAIDs or aspirin: additive gastrointestinal and renal adverse effects.

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal perfusion, monitor kidney function. - Corticosteroids: heightened risk of GI ulceration. - ACE inhibitors or ARBs: may diminish antihypertensive effect and affect renal function. - SSRIs or SNRIs: increased bleeding tendency, monitor for signs of hemorrhage.